Merkler Alexander E, Reynolds Alexandra S, Gialdini Gino, Morris Nicholas A, Murthy Santosh B, Thakur Kiran, Kamel Hooman
Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Department of Neurology, Columbia University Medical Center, New York, NY, United States.
J Neurol Sci. 2017 Apr 15;375:460-463. doi: 10.1016/j.jns.2017.02.051. Epub 2017 Feb 24.
To assess the rate of neurological complications and mortality after tuberculous meningitis in the United States.
The authors performed a retrospective cohort study of all patients 18years or older hospitalized for tuberculous meningitis in California between 2005 and 2010, New York between 2006 and 2012, and Florida between 2005 and 2012. Outcomes of interest were mortality and the following neurological complications: stroke, seizure, hydrocephalus requiring a ventriculoperitoneal shunt, vision impairment, and hearing impairment. Kaplan-Meier survival statistics were used to assess the cumulative rate of neurological complications and death. Cox proportional hazards regression was used to compare rates of complications in patients with and without human immunodeficiency virus (HIV) after adjustment for comorbidities.
806 patients with tuberculous meningitis were identified, among whom the cumulative rate of any complication or death was 55.4% (95% CI, 51.5-59.3%). More than two-thirds of complications occurred during the initial hospitalization for tuberculous meningitis. Individual neurological complications were not uncommon: the cumulative rate of stroke was 16.8% (95% CI, 14.0-20.0%), the rate of seizure was 18.8% (95% CI, 15.4-22.8%), and the rate of ventriculoperitoneal shunting was 8.4% (95% CI, 6.4-10.9%). Vision impairment occurred in 21.6% (95% CI, 18.5-25.1%) of patients and hearing impairment occurred in 6.8% (95% CI, 4.9-9.4%). The mortality rate was 21.5% (95% CI, 18.4-24.9%). Patients with HIV infection were not at increased risk of complications compared to patients without HIV (hazard ratio, 1.2; 95% CI, 0.9-1.6).
Tuberculous meningitis is associated with significant risk of neurological complications and death in the United States.
评估美国结核性脑膜炎后神经并发症发生率及死亡率。
作者对2005年至2010年在加利福尼亚州、2006年至2012年在纽约州以及2005年至2012年在佛罗里达州因结核性脑膜炎住院的所有18岁及以上患者进行了一项回顾性队列研究。感兴趣的结局为死亡率以及以下神经并发症:中风、癫痫发作、需要脑室腹腔分流术的脑积水、视力障碍和听力障碍。采用Kaplan-Meier生存统计评估神经并发症和死亡的累积发生率。使用Cox比例风险回归在调整合并症后比较有和无人免疫缺陷病毒(HIV)患者的并发症发生率。
共识别出806例结核性脑膜炎患者,其中任何并发症或死亡的累积发生率为55.4%(95%CI,51.5 - 59.3%)。超过三分之二的并发症发生在结核性脑膜炎初次住院期间。个别神经并发症并不罕见:中风的累积发生率为16.8%(95%CI,14.0 - 20.0%),癫痫发作率为18.8%(95%CI,15.4 - 22.8%),脑室腹腔分流术率为8.4%(95%CI,6.4 - 10.9%)。21.6%(95%CI,18.5 - 25.1%)的患者出现视力障碍,6.8%(95%CI,4.9 - 9.4%)的患者出现听力障碍。死亡率为21.5%(95%CI,18.4 - 24.9%)。与无HIV患者相比,HIV感染患者并发症风险未增加(风险比,1.2;95%CI,0.9 - 1.6)。
在美国,结核性脑膜炎与神经并发症和死亡的显著风险相关。